CannabisNewsBreaks Archive - Page 60 of 429

ThursdayMar 17, 2022 11:44 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces New Board Appointments

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has made two significant changes to its board. The company named FLGC CEO Luis Merchan as board chair and announced that former Amazon executive Tim Leslie, who is currently serving as chair of Flora Growth’s advisory board, will join the company’s board of directors and audit committee. The company noted that the changes to the board indicate FLGC’s move toward becoming a U.S.-based issuer; the new appointments also support the company’s growth into new international markets. Merchan is replacing Bernie Wilson as board chair;…

ThursdayMar 17, 2022 11:12 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Makes Changes in Management

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, has announced changes in company leadership. According to the announcement, InMed chief financial officer Bruce Colwill is retiring, effective March 31, 2022; Colwill will serve as an advisor to the company through June 30, 2022, to ensure a smooth transition. The company has appointed Brenda Edwards as interim CFO while the company searches for a full-time replacement. Edwards has garnered more than 35 years experience to her new position, including more than two decades of experience as a chief financial officer; she has served…

WednesdayMar 16, 2022 2:29 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Launching Additional Rare Cannabinoids in Response to Inbound Demand

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates and manufacturing technologies for pharmaceutical-grade rare cannabinoids, has dedicated itself to developing new therapeutic alternatives for the treatment of conditions with high unmet medical needs. The manufacturing process used by InMed and its recently acquired subsidiary BayMedica is unparalleled in the industry. “There is no ‘one-size-fits-all’ approach to cannabinoid manufacturing, so multiple avenues are required to realize the maximum outcome for the targeted cannabinoid. InMed and BayMedica, like a well-oiled machine, work together using biosynthesis, chemical synthesis and the proprietary IntegraSyn(TM) manufacturing models,” a recent article explains. “Together,…

WednesdayMar 16, 2022 12:06 pm

CannabisNewsBreaks – Sugarmade Inc. (SGMD) Exploring Potential Move into Omakase Sushi and Cannabis Venture Space

Sugarmade (OTC: SGMD), an emerging company in the licensed cannabis sector, today announced that it is exploring a possible joint venture with a well-established business to create access to the Los Angeles reservation-only omakase sushi restaurant marketplace. According to the update, the joint venture may include an on-site cannabis event area and cannabis delivery services hub. “We believe this presents a tremendous opportunity for Sugarmade to break into a new market that aligns well with our established expertise and infrastructure,” said Jimmy Chan, CEO of Sugarmade. “On-site cannabis consumption is still extremely rare at dining establishments in LA. The omakase…

TuesdayMar 15, 2022 3:42 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Commencement of DehydraTECH-CBD Epilepsy Research Program

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that the first phase of its epilepsy research program EPIL-A21-1 is beginning this week. According to the update, the DehydraTECH(TM)-CBD test articles needed to commence dosing have already been manufactured and delivered to the third-party laboratory engaged to complete this research program. EPIL-A21-1 will assess the seizure inhibiting activity of DehydraTECH-CBD compared to the world's only FDA-approved CBD-based seizure medication, Epidiolex(R). Lexaria hopes to demonstrate superior performance based on DehydraTECH’s known advanced drug delivery capabilities. Lexaria's seizure program expects to leverage the significant gains in systemic…

TuesdayMar 15, 2022 12:21 pm

CannabisNewsBreaks – Flora Growth Corp.’s (NASDAQ: FLGC) Announces Receipt of 2022 Export Quota for High-THC Cannabis

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has received its annual export quote from the Colombian Ministry of Health and Social Protection. The company announced that the quota is for a total of 43,600 kg of high-THC cannabis, an updated quota that allows adequate export of medical cannabis products to meet Flora’s existing and future supply agreements in both bulk dry flower and derivatives. That allotment means Flora can produce and export both high-THC dry flower and cannabis derivative products and start to fulfill its previously announced agreements, including the agreement…

TuesdayMar 15, 2022 10:54 am

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Medical Device Registration in New Zealand for Proprietary IoT System

RYAH Group (CSE: RYAH) today announced that its subsidiary, RYAH Medtech Inc., has received a medical device certification in New Zealand for its proprietary Internet of Things (“IoT”) powered medical cannabis inhaler, proprietary cartridges and software application associated with the device (the “RYAH Smart Medical Inhaler System”). This comes in coordination with Medical Kiwi Ltd. as local sponsor for the New Zealand certification. Medical Kiwi is a New Zealand-based leader in R&D, manufacturing, cultivation and distribution of medical cannabis and medical devices. “We are pleased to continue gaining traction with medical device registration around the world and are excited to…

MondayMar 14, 2022 3:19 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Enters Agreement to Bring Mind Naturals to Hong Kong and Key Global Markets

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its entry into a distribution agreement with Israel-based DNO Group to distribute the Mind Naturals brand in the Hong Kong region. A leading distributor of global independent brands, DNO Group has over 50,000 points of sale throughout Asia in addition to its broader global reach. Under the agreement, Flora will work with DNO to identify growth opportunities and, using an omnichannel approach including brick-and-mortar retail, e-commerce and wholesale, bring the Mind Naturals brand to market in new territories. The initial focus will be…

MondayMar 14, 2022 2:50 pm

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) to Share Its Story at the 34th Annual Roth Conference

Advanced Container Technologies (OTC: ACTX) today announced that its key executives will be attending the 34th Annual Roth Conference, which is taking place in Laguna Niguel, California, from March 13-15, 2022. The conference is one of the largest of its type in the nation, focusing on small-cap businesses and featuring company presentations, question-and-answer sessions, and one-on-one meetings. ACTX’s long-term growth strategy focuses on several key inter-related vertical markets that provide unique synergy and opportunities. The company's chief initiative is to revolutionize the direct-to-consumer food delivery (“meal kit”) market. “In 2020, amidst a global pandemic, we were able to make key…

ThursdayMar 10, 2022 11:44 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Acquisition Expected to Provide Significant Growth Acceleration

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, recently acquired JustCBD, a market leader in the consumable cannabinoid market. The acquisition is expected to provide meaningful growth acceleration and deliver human capital to the Flora organization and strengthen its foothold in the U.S. wellness market. In addition, there is significant opportunity to leverage Flora’s economically-advantaged cultivation to support expansion of the JustCBD brand across the global market. Roth served as exclusive financial advisor to JustCBD on the transaction. To view the full press release, visit https://cnw.fm/CYSwg About Flora Growth Corp. Flora is building…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

CannabisNewsBreaks